Start Date: 04/05/2016

End Date: 06/05/2016

Cost: tbc

Venue: Wellcome Genome Campus, Hinxton, Cambridge, UK

Organiser:

Wellcome Genome Campus Scientific Conferences

Contact Details:

lucy.criddle@wellcomegenomecampus.org

Comments:

We are pleased to announce the 2nd in our series of meetings on mitochondrial disorders and the quest for novel effective therapies. Mitochondrial diseases form the largest group of inherited metabolic disorders, and the past decade has seen major advances in our understanding of the molecular mechanisms involved. Novel therapeutic strategies are being developed based on this new knowledge, and preclinical studies in animal models show great promise. This conference will bring together world leaders in the field of translational mitochondrial medicine in an interactive programme designed to engage and inspire a new generation of mitochondrial researchers, who will harness this new technology to prevent and treat these devastating diseases. The meeting attracts international participants interested in mitochondrial diseases, working in molecular genetics, biochemistry, pathology, and clinical medicine. Scientific programme committee Patrick Chinnery (University of Cambridge, UK) Marni Falk (The Children’s Hospital of Philadelphia, USA) Vamsi Mootha (Harvard Medical School, USA) Jan Smeitink Radboud (UMC, The Netherlands) Anu Suomalainen (University of Helsinki, Finland) Massimo Zeviani (MRC Mitochondrial Biology Unit, Cambridge, UK)

Link: https://registration.hinxton.wellcome.ac.uk/events/item.aspx?e=572